Japan-based Takeda Pharmaceutical Company Limited, a research-based pharmaceutical company, engages in the manufacture, marketing, and import/export of pharmaceutical drugs worldwide. The company markets its original products, such as the anti-prostatic cancer agent leuprolide acetate (marketed as Lupron Depot, Enantone, Prostap, and Leuplin), the anti-peptic ulcer agent lansoprazole (marketed as Prevacid, Ogast, Takepron, and other names), the anti-hypertensive agent candesartan cilexetil (marketed as Blopress, Kenzen, and Amias), and the anti-diabetic agent pioglitazone hydrochloride (marketed as Actos). Segments The company operates its business in two categories, Pharmaceutical business and Other businesses. The Pharmaceutical business represents the ethical drug business and healthcare business. Other businesses include business activities involving the production and marketing of a range of products, including vitamin bulks, test reagents & clinical diagnostics, photographic chemicals, and inorganic chemicals. Takeda provides products in the therapeutic areas of allergy, cardiovascular, central nervous system, diabetes, gastrointestinal, gout, infection, inflammation, interleukin, oncology, osteoporosis, and urology and gynecology, as well as offers vaccines and vitamins. In addition, the company offers over-the-counter drugs, including cold remedies, gastrointestinal drugs, vitamin products, vitamin-containing tonics, athlete's foot treatments, and laxatives. Further, it is involved in the production and sale of reagents, clinical diagnostics, and chemical products.